{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:02:18Z","timestamp":1788282138091,"version":"build-2803163510"},"reference-count":52,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Ulcerative colitis (UC) is a chronic inflammatory disease with highly variable symptoms and severity. Prognostic models for UC support precision medicine by enabling personalized treatment strategies. However, the quality and clinical utility of these models remain inadequately assessed.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to systematically review and critically evaluate the development, performance, and applicability of prognostic prediction models for UC.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n To identify prognostic models for UC, a comprehensive search was conducted in PubMed, Embase, the Cochrane Library, Web of Science, SinoMed, China National Knowledge Infrastructure, Wanfang, and VIP Database up to November 2, 2024. Extracted data included study characteristics, model development methods, validation metrics (eg, area under the curve and concordance index). The risk of bias and applicability were evaluated using the Prediction Model Risk of Bias Assessment Tool. A meta-analysis was conducted to assess model performance.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 30 studies involving 7452 patients with UC were included, with the largest numbers conducted in China (11\/30, 37%) and Japan (4\/30, 13%). Most studies were retrospective (22\/30, 73%). The primary objectives of the UC prognostic models included predicting therapeutic effects and responses to treatment, particularly to tumor necrosis factor-alpha inhibitors (eg, infliximab and adalimumab), and assessing the risks of surgery, disease progression, or relapse. Logistic regression was the most frequently used method for both predictor selection (6\/30, 20%) and model construction (12\/30, 40%). Common predictors included age, C-reactive protein, albumin, hemoglobin, disease extent, and Mayo scores. The meta-analysis yielded a pooled area under the curve of 0.84 (95% CI 0.77\u20100.92). Most studies exhibited a high risk of bias (29\/30, 97%), particularly in participant selection and statistical analysis. Applicability concerns were identified in 18 studies (18\/30, 60%), primarily due to subgroup-specific designs that limited the generalizability of the findings. External validation data (14\/30, 47%) were limited, and only a small number of studies (12\/30, 40%) included calibration curves or decision curve analysis.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study demonstrates that prognostic models for UC have some potential in predictive performance and clinical application. However, most models are constrained by high bias risk, insufficient external validation, and limited generalizability due to small sample sizes and subgroup-specific designs. Future research should prioritize multicenter validations, refine model development approaches, and enhance model applicability to support broader clinical implementation.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/71944","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:14:27Z","timestamp":1766434467000},"page":"e71944-e71944","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Prediction Models for Ulcerative Colitis: Systematic Review and Meta-Analysis"],"prefix":"10.2196","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0051-1662","authenticated-orcid":false,"given":"Zhijun","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0519-5907","authenticated-orcid":false,"given":"Yuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5708-7709","authenticated-orcid":false,"given":"Zeyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2986-9358","authenticated-orcid":false,"given":"Liming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7176-7726","authenticated-orcid":false,"given":"Chuanlan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-2106","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8754-8849","authenticated-orcid":false,"given":"Jing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0705-9192","authenticated-orcid":false,"given":"Huiyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0320-061X","authenticated-orcid":false,"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-1578","authenticated-orcid":false,"given":"Zhaolan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"8","key":"R1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jama.2023.23814","article-title":"What is ulcerative colitis?","volume":"331","author":"Voelker","journal-title":"JAMA"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.2196\/60019","article-title":"Application of internet hospitals in the disease management of patients with ulcerative colitis: retrospective study","volume":"27","author":"Yu","journal-title":"J Med Internet Res"},{"issue":"10114","key":"R3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","journal-title":"Lancet"},{"issue":"8067","key":"R4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","journal-title":"Nature New Biol"},{"issue":"10114","key":"R5","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1016\/S0140-6736(17)32669-7","article-title":"Rapid changes in epidemiology of inflammatory bowel disease","volume":"390","author":"Kamm","journal-title":"Lancet"},{"issue":"10080","key":"R6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","journal-title":"Lancet"},{"issue":"4","key":"R7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I","volume":"24","author":"Knowles","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"R8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands","journal-title":"Gastroenterology"},{"issue":"2","key":"R9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.gastro.2016.09.046","article-title":"Management strategies to improve outcomes of patients with inflammatory bowel diseases","volume":"152","author":"Colombel","journal-title":"Gastroenterology"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.2196\/67201","article-title":"A knowledge-enhanced platform (MetaSepsisKnowHub) for retrieval augmented generation-based sepsis heterogeneity and personalized management: development study","volume":"27","author":"Zhang","journal-title":"J Med Internet Res"},{"issue":"23","key":"R11","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine--personalized, problematic, and promising","volume":"372","author":"Jameson","journal-title":"N Engl J Med"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","journal-title":"BMJ"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","journal-title":"Ann Intern Med"},{"issue":"7","key":"R14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/apt.18190","article-title":"A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis","volume":"60","author":"Croft","journal-title":"Aliment Pharmacol Ther"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2024.08.021","article-title":"A predictive machine-learning model for clinical decision-making in washed microbiota transplantation on ulcerative colitis","volume":"24","author":"Zhang","journal-title":"Comput Struct Biotechnol J"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/a-1960-3645","article-title":"A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity\/remission and predict clinical outcomes in ulcerative colitis","volume":"55","author":"Iacucci","journal-title":"Endoscopy"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742080","article-title":"Artificial neural network analysis-based immune-related signatures of primary non-response to infliximab in patients with ulcerative colitis","volume":"12","author":"Chen","journal-title":"Front Immunol"},{"issue":"5","key":"R18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cgh.2018.08.068","article-title":"Colonic microRNA profiles, identified by a deep learning algorithm, that predict responses to therapy of patients with acute severe ulcerative colitis","volume":"17","author":"Morilla","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"R19","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/ibd\/izab030","article-title":"Computational learning of microRNA-based prediction of pouchitis outcome after restorative proctocolectomy in patients with ulcerative colitis","volume":"27","author":"Morilla","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"R20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131197","article-title":"Computer-aided prediction of long-term prognosis of patients with ulcerative colitis after cytoapheresis therapy","volume":"10","author":"Takayama","journal-title":"PLoS One"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2023.102297","article-title":"Development and multiple visualization methods for the therapeutic effects prediction model of five-flavor Sophora Flavescens enteric-coated capsules in the treatment of active ulcerative colitis: a study on model development and result visualization","volume":"63","author":"Bu","journal-title":"Eur J Integr Med"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac029","article-title":"Development and validation of a nomogram to predict indolent course in patients with ulcerative colitis: a single-center retrospective study","volume":"10","author":"Li","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"R23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.17235\/reed.2023.9703\/2023","article-title":"Development and validation of a nomogram to predict non-response to 5-aminosalicylic acid in patients with ulcerative colitis","volume":"116","author":"Dai","journal-title":"Rev Esp Enferm Dig"},{"issue":"12","key":"R24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/17474124.2023.2279737","article-title":"Development and validation of a risk model to predict the progression of ulcerative colitis patients to acute severe disease within one year","volume":"17","author":"Chen","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac053","article-title":"Development and validation of novel models for the prediction of intravenous corticosteroid resistance in acute severe ulcerative colitis using logistic regression and machine learning","volume":"10","author":"Yu","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"5","key":"R26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.5009\/gnl210369","article-title":"Exploration of potential gut microbiota-derived biomarkers to predict the success of fecal microbiota transplantation in ulcerative colitis: a prospective cohort in Korea","volume":"16","author":"Kang","journal-title":"Gut Liver"},{"issue":"6","key":"R27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/apt.14510","article-title":"Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis","volume":"47","author":"Waljee","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96019-x","article-title":"Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis","volume":"11","author":"Miyoshi","journal-title":"Sci Rep"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55126-1","article-title":"Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis","volume":"14","author":"Morikubo","journal-title":"Sci Rep"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2022.03.006","article-title":"Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis","volume":"246","author":"Ghiassian","journal-title":"Transl Res"},{"issue":"24","key":"R31","doi-asserted-by":"publisher","first-page":"12781","DOI":"10.26355\/eurrev_202012_24178","article-title":"New perspectives in the prediction of postoperative complications for high-risk ulcerative colitis patients: machine learning preliminary approach","volume":"24","author":"Sofo","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.678424","article-title":"Novel gene signatures predicting primary non-response to infliximab in ulcerative colitis: development and validation combining random forest with artificial neural network","volume":"8","author":"Feng","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"R33","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.dld.2024.06.008","article-title":"Precision medicine: externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis","volume":"56","author":"Konikoff","journal-title":"Dig Liver Dis"},{"issue":"3","key":"R34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/ecco-jcc\/jjw159","article-title":"Predicting the individual risk of acute severe colitis at diagnosis","volume":"11","author":"Cesarini","journal-title":"J Crohns Colitis"},{"issue":"11","key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21154","article-title":"Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: a prospective study","volume":"9","author":"Derakhshan Nazari","journal-title":"Heliyon"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14010002","article-title":"Prediction of clinical remission with adalimumab therapy in patients with ulcerative colitis by Fourier transform-infrared spectroscopy coupled with machine learning algorithms","volume":"14","author":"Kim","journal-title":"Metabolites"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211054710","article-title":"Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies","volume":"14","author":"Lees","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"R38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/jgh3.12342","article-title":"Prediction of outcome of treatment of acute severe ulcerative colitis using principal component analysis and artificial intelligence","volume":"4","author":"Ghoshal","journal-title":"JGH Open"},{"issue":"6","key":"R39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10151-022-02602-3","article-title":"Prediction of pouchitis after ileal pouch-anal anastomosis in patients with ulcerative colitis using artificial intelligence and deep learning","volume":"26","author":"Mizuno","journal-title":"Tech Coloproctol"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S423086","article-title":"Serological biomarker-based machine learning models for predicting the relapse of ulcerative colitis","volume":"16","author":"Pang","journal-title":"J Inflamm Res"},{"issue":"2","key":"R41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/10543406.2021.2009500","article-title":"Using supervised machine learning approach to predict treatment outcomes of vedolizumab in ulcerative colitis patients","volume":"32","author":"Chen","journal-title":"J Biopharm Stat"},{"issue":"10","key":"R42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.19538\/j.cjps.issn1005-2208.2023.10.18","article-title":"Prediction of pouchitis after ileal pouch-anal anastomosis based on clinical nomogram of perioperative factors","volume":"43","author":"Wang","journal-title":"Chin J Pract Surg"},{"issue":"4","key":"R43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3969\/j.issn.1006-2157.2023.04.012","article-title":"Construction of an efficacy prediction model for active ulcerative colitis","volume":"46","author":"Wang","journal-title":"J Beijing Univ Tradit Chin Med"},{"issue":"4","key":"R44","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1467-985X.2009.00614_16.x","article-title":"Clinical prediction models\u2014a practical approach to development, validation and updating","volume":"172","author":"Bedogni","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"2","key":"R45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/ibd\/izae179","article-title":"The composition of the fecal and mucosa-adherent microbiota varies based on age and disease activity in ulcerative colitis","volume":"31","author":"Malham","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"R46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/ecco-jcc\/jjae007","article-title":"Achievement of clinical, endoscopic, and histological outcomes in patients with ulcerative colitis treated with etrasimod, and association with faecal calprotectin and C-reactive protein: results from the phase 2 OASIS trial","volume":"18","author":"Yarur","journal-title":"J Crohn Colitis"},{"issue":"11","key":"R47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224365","article-title":"Machine learning algorithm validation with a limited sample size","volume":"14","author":"Vabalas","journal-title":"PLoS One"},{"issue":"2","key":"R48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gie.2023.04.2074","article-title":"Diagnostic accuracy of convolutional neural network-based machine learning algorithms in endoscopic severity prediction of ulcerative colitis: a systematic review and meta-analysis","volume":"98","author":"Jahagirdar","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"R49","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae198","article-title":"Artificial intelligence\u2013enabled histology exhibits comparable accuracy to pathologists in assessing histological remission in ulcerative colitis: a systematic review, meta-analysis, and meta-regression","volume":"19","author":"Puga-Tejada","journal-title":"J Crohn Colitis"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","journal-title":"BMJ"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","journal-title":"BMJ"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","journal-title":"BMJ"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2025\/1\/e71944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:01:52Z","timestamp":1782842512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2025\/1\/e71944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":52,"URL":"https:\/\/doi.org\/10.2196\/71944","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"article-number":"v27i8e71944"}}